Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China
· Delayed Price · Currency is CNY 35.25
+0.47 (1.35%)
At close: Apr 29, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 3.81 billion as of April 29, 2026. Its market cap has increased by 105.06% in one year.
Market Cap
3.81B
Enterprise Value
3.05B
Revenue
197.68M
Ranking
n/a
PE Ratio
65.83
Stock Price
35.25
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 3.81B, a decrease of -36.26%. That is a compound annual growth rate of -10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.76B | 59.76% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.77B |
| Zhejiang Wecome Pharmaceutical Company | 3.76B |
| Qingdao Vland Biotech INC. | 3.72B |
| Baolingbao Biology | 3.87B |
| Zhejiang Shouxiangu Pharmaceutical | 3.62B |
| Shanghai Shen Lian Biomedical | 3.58B |
| Hinova Pharmaceuticals | 4.06B |
| Boji Medical Technology | 4.07B |